University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, 27514, United States
NCT Number: NCT01539759
This is a randomized controlled trial among women who deliver by cesarean at UNC Women's Hospital and desire an Intrauterine Device (IUD) for contraception postpartum. After consenting, women will be randomized to receive an IUD at time of cesarean delivery or at a postpartum visit 4-8 weeks later. After randomization, subjects will be given a choice of the Mirena® IUD or the Paragard® IUD. Data collection will occur at baseline, delivery, the 4-8 week postpartum visit, and 2 follow-up encounters at 3 and 6 months. We hypothesize that women who receive an IUD at the time of cesarean will be more likely to use an IUD 6 months later than women who plan on receiving an IUD 4-8 weeks after delivery.
Looking for future studies?
Notify Me18 year–45 year
Female
Interventional
Not applicable
Chapel Hill, North Carolina, 27514, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Women randomized to this arm will have an IUD placed during their cesarean delivery, immediately after delivery of the placenta
Time frame: 6 months postpartum
The use of an IUD at 6 months postpartum is the primary outcome measure
Time frame: 0-6 months postpartum
Time frame: 0-6 months postpartum
University of North Carolina, Chapel Hill
Other
Immediate Postplacental Insertion of Intrauterine Devices at Time of Cesarean Delivery: A Randomized Clinical Trial
Acronym: IUD@CSD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03754556
Behavior, Breast Feeding
Oakland, California, United States
View Trial DetailsNCT01175161
Africa, Contraception
Lilongwe, Malawi
View Trial DetailsNCT07046572
Endometrial Biopsy, Intrauterine Devices
Toronto, Ontario, Canada
View Trial DetailsNCT07720440
Agnosia, Behavior
Istanbul, Sultangazi, Turkey (Türkiye)
View Trial Details